Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Wounds and Injuries 1Peripheral Nervous System Diseases 1Pain 1Neuralgia 1Neoplasms 1Lymphoma, Follicular 1HIV Infections 1Bronchiolitis Obliterans Syndrome 1Acquired Immunodeficiency Syndrome 1AIDS-Related Complex 1

Interventions

Fentanyl 19Analgesia 15Acupuncture Therapy 13Oxycodone 12Zoledronic Acid 11Surveys and Questionnaires 10nabiximols 9Therapeutics 9Morphine 9Acetaminophen 9Psychiatric Rehabilitation 8Ketamine 8Hydromorphone 7Lidocaine 6Ibandronic Acid 6Radiotherapy 5Early Intervention, Educational 5Bupivacaine 5Analgesics, Opioid 5Yoga 4Transcutaneous Electric Nerve Stimulation 4Therapeutic Touch 4Ropivacaine 4Music Therapy 4Methadone 4Massage 4Aromatherapy 4alvimopan 3Tapentadol 3Saline Solution 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Pain × ziconotide × Clear all
NCT00002160 2005-06-24

A Multicenter Phase II/III, Placebo-Controlled Study of SNX-111 Administered Intrathecally to Cancer and AIDS Patients With Chronic Pain

NIH AIDS Clinical Trials Information Service

Phase 2 Completed
100 enrolled

Acquired Immunodeficiency Syndrome, AIDS-Related Complex, Neoplasms, Pain, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡